Akero Therapeutics Inc (AKRO)
20.90
+0.11
(+0.53%)
USD |
NASDAQ |
Apr 23, 09:57
Akero Therapeutics Max Drawdown (5Y)
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
Madrigal Pharmaceuticals Inc | 82.20% |
89bio Inc | -- |
Viking Therapeutics Inc | 89.26% |
Eli Lilly and Co | 22.48% |
Ionis Pharmaceuticals Inc | 70.27% |